BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 28063228)

  • 1. TRIM33 is essential for osteoblast proliferation and differentiation via BMP pathway.
    Guo J; Qin W; Xing Q; Gao M; Wei F; Song Z; Chen L; Lin Y; Gao X; Lin Z
    J Cell Physiol; 2017 Nov; 232(11):3158-3169. PubMed ID: 28063228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.
    Sowa H; Kaji H; Hendy GN; Canaff L; Komori T; Sugimoto T; Chihara K
    J Biol Chem; 2004 Sep; 279(39):40267-75. PubMed ID: 15150273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological Silicon Stimulates Collagen Type 1 and Osteocalcin Synthesis in Human Osteoblast-Like Cells Through the BMP-2/Smad/RUNX2 Signaling Pathway.
    Dong M; Jiao G; Liu H; Wu W; Li S; Wang Q; Xu D; Li X; Liu H; Chen Y
    Biol Trace Elem Res; 2016 Oct; 173(2):306-15. PubMed ID: 27025722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilose antler aqueous extract promotes the proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells by stimulating the BMP-2/Smad1, 5/Runx2 signaling pathway.
    Ren C; Gong W; Li F; Xie M
    Chin J Nat Med; 2019 Oct; 17(10):756-767. PubMed ID: 31703756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
    Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
    J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β inhibits osteogenesis by upregulating the expression of ubiquitin ligase SMURF1 via MAPK-ERK signaling.
    Sun X; Xie Z; Ma Y; Pan X; Wang J; Chen Z; Shi P
    J Cell Physiol; 2018 Jan; 233(1):596-606. PubMed ID: 28322449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of adenosine monophosphate-activated protein kinase suppresses bone morphogenetic protein-2-induced mineralization of osteoblasts via Smad-independent mechanisms.
    Takeno A; Kanazawa I; Notsu M; Tanaka KI; Sugimoto T
    Endocr J; 2018 Mar; 65(3):291-298. PubMed ID: 29249772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linarin promotes osteogenic differentiation by activating the BMP-2/RUNX2 pathway via protein kinase A signaling.
    Li J; Hao L; Wu J; Zhang J; Su J
    Int J Mol Med; 2016 Apr; 37(4):901-10. PubMed ID: 26935542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.
    Yonezawa T; Lee JW; Hibino A; Asai M; Hojo H; Cha BY; Teruya T; Nagai K; Chung UI; Yagasaki K; Woo JT
    Biochem Biophys Res Commun; 2011 Jun; 409(2):260-5. PubMed ID: 21570953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shikonin stimulates MC3T3-E1 cell proliferation and differentiation via the BMP-2/Smad5 signal transduction pathway.
    Fang T; Wu Q; Mu S; Yang L; Liu S; Fu Q
    Mol Med Rep; 2016 Aug; 14(2):1269-74. PubMed ID: 27279141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone-responsive Smad3-related factor, Tmem119, promotes osteoblast differentiation and interacts with the bone morphogenetic protein-Runx2 pathway.
    Hisa I; Inoue Y; Hendy GN; Canaff L; Kitazawa R; Kitazawa S; Komori T; Sugimoto T; Seino S; Kaji H
    J Biol Chem; 2011 Mar; 286(11):9787-96. PubMed ID: 21239498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core-binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5.
    Nishimura R; Hata K; Harris SE; Ikeda F; Yoneda T
    Bone; 2002 Aug; 31(2):303-12. PubMed ID: 12151083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype.
    Phimphilai M; Zhao Z; Boules H; Roca H; Franceschi RT
    J Bone Miner Res; 2006 Apr; 21(4):637-46. PubMed ID: 16598384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on osteoblast differentiation.
    Spinella-Jaegle S; Roman-Roman S; Faucheu C; Dunn FW; Kawai S; Galléa S; Stiot V; Blanchet AM; Courtois B; Baron R; Rawadi G
    Bone; 2001 Oct; 29(4):323-30. PubMed ID: 11595614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoride promotes viability and differentiation of osteoblast-like Saos-2 cells via BMP/Smads signaling pathway.
    Huo L; Liu K; Pei J; Yang Y; Ye Y; Liu Y; Sun J; Han H; Xu W; Gao Y
    Biol Trace Elem Res; 2013 Oct; 155(1):142-9. PubMed ID: 23918166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sprouty2 is involved in the control of osteoblast proliferation and differentiation through the FGF and BMP signaling pathways.
    Taketomi T; Onimura T; Yoshiga D; Muratsu D; Sanui T; Fukuda T; Kusukawa J; Nakamura S
    Cell Biol Int; 2018 Sep; 42(9):1106-1114. PubMed ID: 28921936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interferon-inducible p204 protein acts as a transcriptional coactivator of Cbfa1 and enhances osteoblast differentiation.
    Liu CJ; Chang E; Yu J; Carlson CS; Prazak L; Yu XP; Ding B; Lengyel P; Di Cesare PE
    J Biol Chem; 2005 Jan; 280(4):2788-96. PubMed ID: 15557274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myricetin induces human osteoblast differentiation through bone morphogenetic protein-2/p38 mitogen-activated protein kinase pathway.
    Hsu YL; Chang JK; Tsai CH; Chien TT; Kuo PL
    Biochem Pharmacol; 2007 Feb; 73(4):504-14. PubMed ID: 17113042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The suppressive effect of myeloid Elf-1-like factor (MEF) in osteogenic differentiation.
    Kim YJ; Kim BG; Lee SJ; Lee HK; Lee SH; Ryoo HM; Cho JY
    J Cell Physiol; 2007 Apr; 211(1):253-60. PubMed ID: 17167770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
    Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H
    Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.